In the majority of cases, CF sufferers will die as a result of chronic bacterial lung infections. The need to maintain lung function in these patients means that characterising of these infections is vital. Recent molecular based studies have shown the level of bacterial diversity in CF sputum to be much higher than previously accepted. Understanding the CF lung in terms of its microbial ecology could benefit our understanding of disease progression and influence treatment regimens. DNA derived signals can originate from both viable and non-viable cells. In order to draw ecological conclusions from community-based analyses of samples from the CF lung it is important to focus analysis on viable bacteria. To ensure only DNA from viable cells are analysed, samples can be treated with propidium monoazide (PMA), a membrane impermeable dye that interacts with extracellular DNA or DNA within non-viable cells, to prevent PCR amplification. Here, the impact of PMA treatment on 16S rDNA pyrosequencing-based characterisation of CF lung microbial communities was assessed. Parallel community characterisation was performed on treated and untreated sputum sample aliquots from adult CF patients, with the resulting data compared statistically. PMA treatment significantly impacts characterisation of bacterial communities in CF sputum samples when applied in conjunction with 16S rDNA pyrosequencing analysis, this may have significant impact on future treatment regimes. Conclusions: Social deprivation is associated with an increased risk of Pseudomonas colonisation, but a lower risk of Staphylococcus colonisation in young people with cystic fibrosis in the UK. We speculate that patients from more deprived areas may spend more time in hospital and thus have greater exposure to other patients with PA. We acknowledge the support of the MRC and the UK Cystic Fibrosis Trust.
